Investigation of ACE, ACE2 and AGTR1 genes for association with nephropathy in Type 1 diabetes mellitus

Diabetic Medicine

Volumn 27, Issue 10, 2010, Pages 1188-1194

  Currie, D ^a   McKnight, A J ^a   Patterson, C C ^a   Sadlier, D M ^b   Maxwell, A P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

ACE; AGTR1; association; diabetes; nephropathy

Indexed keywords

ACE GENE; ACE2 GENE; ADOLESCENT; ADULT; AGTR1 GENE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; GEL ELECTROPHORESIS; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREAT BRITAIN; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 77956853546     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03097.x     Document Type: Article

References (32)

1. US Renal Data System. USRDS 2008 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethseda, MD : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008.
2. Conway BR, Savage DA, Maxwell AP. Identifying genes for diabetic nephropathy - current difficulties and future directions. Nephrol Dial Transplant 2006 21 : 3012 3017.
3. Brown NJ, Blais C Jr., Gandhi SK, Adam A. ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 1998 32 : 373 377.
4. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990 86 : 1343 1346.
5. Ueda S, Elliot HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype DD for angiotensin-converting enzyme. Hypertension 1995 25 : 1266 1269.
6. Rudberg S, Rasmussen LM, Bangstad HJ, Osterby R. Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria. Diabetes Care 2000 23 : 544 548.
7. Jacobsen PK, Tarnow L, Parving HH. Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy. Kidney Int 2006 69 : 1293 1295.
8. Costa-Scharplatz M, van Asselt AD, Bachmann LM, Kessels AG, Severens JL. Cost-effectiveness of pharmacogenetic resting to predict treatment response to angiotensin-converting enzyme inhibitor. Pharmocogenet Genomics 2007 17 : 359 368.
9. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000 87 : E1 E9.
10. Burns KD. The emerging role of angiotensin-converting enzyme-2 in the kidney. Curr Opin Nephrol Hypertens 2007 16 : 116 121.
11. Palatini P, Ceolotto G, Dorigatti F, Mos l, Santonastaso M, Bratti P et al. Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. Am J Hypertens 2009 22 : 208 214.
12. Su S, Chen J, Zhao J, Huang J, Wang X, Chen R et al. Angiotensin II type I receptor gene and myocardial infarction: tagging SNPs and haplotype based association study. The Beijing atherosclerosis study. Pharmacogenetics 2004 14 : 673 681.
13. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994 344 : 910 913.
14. van Geel PP, Pinto YM, Zwinderman AH, Henning RH, van Boven AJ, Jukema JW et al. Increased risk for ischaemic events is related to combined RAS polymorphism. Heart 2001 85 : 458 462.
15. Coll E, Campos B, González-Núñez D, Botey A, Poch E. Association between the A1166C polymorphism of the angiotensin II receptor type 1 and progression of chronic renal insufficiency. J Nephrol 2003 16 : 357 364.
16. Alvarez R, Reguero JR, Batalla A, Iglesias-Cubero G, Cortina A, Alvarez V et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism: association with early coronary artery disease. Cardiovasc Res 1998 40 : 375 379.
17. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992 20 : 1433.
18. Mancini FP, Margaglione M, Tufano A, Celentano A, Ferrara LA, Colantuoni V et al. A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. Circulation 1998 97 : 1213 1214.
19. Wang K, Dickson SP, Stolle CA, Krantz IA, Goldstein DB, Hakonarson H. Interpretation of association signals and identification of causal variants from genome-wide association studies. Am J Hum Genet 2010 86 : 730 742.
20. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003 348 : 2285 2293.
21. Rice GI, Jones AL, Grant PJ, Carter AM, Turner AJ, Hooper NM. Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin- converting enzyme 2, and neprilysin in a family study. Hypertension 2006 48 : 914 920.
22. Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Bhansali A, Sud K et al. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol 2009 28 : 141 150.
23. Xue Y, Cheng Y, Zhou L, Luo R, Guan M, Zhang X. Association between Angiotensin II receptor gene type I polymorphism and diabetic nephropathy in type 2 diabetes mellitus. Zhonghua Nei Ke Za Zhi 2001 40 : 173 175.
24. Osawa N, Koya D, Araki S, Uzu T, Tsunoda T, Kashiwagi A et al. Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet 2007 52 : 143 151.
25. Möllsten A, Kockum I, Svensson M, Rudberg S, Ugarph-Morawski A, Brismar K et al. The effect of polymorphisms in the renin-angiotensin- aldosterone system on diabetic nephropathy risk. J Diabetes Complications 2008 22 : 377 383.
26. Eriksson U, Daniczyk U, Penninger JM. Just the beginning: novel functions for angiotensin-converting enzymes. Curr Biol 2002 12 : R745 752.
27. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD et al. The emerging role of ACE2 in physiology and disease. J Pathol 2007 212 : 1 11.
28. Niu W, Qi Y, Hou S, Zhou W, Qiu C. Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese. Trans Res 2007 150 : 374 380.
29. Yi L, Gu YH, Wang XL, An LZ, Xie XD, Shao W et al. Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. J Int Med Res 2006 34 : 272 283.
30. Zhong J, Yan Z, Liu D, Ni Y, Zhao Z, Zhu S et al. Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. J Lab Clin Med 2006 147 : 91 95.
31. Zhou JB, Yang JK. Meta-analysis of association of ACE2 G8790A polymorphism with Chinese Han essential hypertension. J Renin Angiotensin Aldosterone Syst 2009 10 : 31 34.
32. Fröjdö S, Sjölind L, Parkkonen M, Mäkinen VP, Kilpikari R, Pettersson-Fernholm K et al. Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy. Diabetologia 2005 48 : 2278 2281.